Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia.
Status:
Completed
Trial end date:
2013-06-18
Target enrollment:
Participant gender:
Summary
To compare the treatment of gullet cancer with radiotherapy alone and assess the advantage
and toxicity of adding chemotherapy. The hypothesis to be tested is as follows: That the
addition of chemotherapy to a short course of radiation treatment improves the proportion of
patients who achieve relief of dysphagia and improves quality of life compared to radiation
alone in patients with advanced oesophageal cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Trans Tasman Radiation Oncology Group Trans-Tasman Radiation Oncology Group (TROG)
Collaborators:
Canadian Cancer Trials Group National Health and Medical Research Council, Australia NCIC Clinical Trials Group